An induced pluripotent stem cell line (GZHMCi004-A) derived from a fetus with heterozygous G380R mutation in FGFR3 gene causing achondroplasia

被引：0
|
作者：
Li, Nan [1 ]
Lin, Sheng Mou [2 ]
Li, Yingting [1 ]
Sun, Jimei [1 ]
Zhang, Luting [1 ]
Chen, Min [1 ]
机构：
[1] Guangzhou Med Univ, Affiliated Hosp 3, Dept Obstet & Gynecol, Dept Fetal Med & Prenatal Diag,Key Lab Major Obst, Guangzhou, Peoples R China
[2] Univ Hong Kong, Shenzhen Hosp, Dept Obstet & Gynecol, Shenzhen 518053, Peoples R China
来源：
STEM CELL RESEARCH | 2021年 / 53卷
关键词：
D O I：
10.1016/j.scr.2021.102322
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Achondroplasia (ACH; MIM #100800) is an autosomal dominant genetic disease caused by gain-of-function mutations in FGFR3 gene and results in short-limb dwarfism. Here, we generated an induced pluripotent stem cell line GZHMCi004-A derived from umbilical cord blood mononuclear cells (UCBMCs) of a fetus with heterozygous G380R mutation in FGFR3 gene. This iPSC line is a valuable in vitro model to study the pathological mechanism and the treatment of ACH.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene
    Pehlivan, S
    Özkinay, F
    Okutman, Ö
    Çogulu, Ö
    Özcan, A
    Çankaya, T
    Ülgenalp, A
    TURKISH JOURNAL OF PEDIATRICS, 2003, 45 (02) : 99 - 101
  • [2] Psychomotor Delay in a Child with FGFR3 G380R Pathogenic Mutation Causing Achondroplasia
    Ergoren, Mahmut C.
    Eren, Erdal
    Manara, Elena
    Paolacci, Stefano
    Tulay, Pinar
    Sag, Sebnem O.
    Bertelli, Matteo
    Mocan, Gamze
    Temel, Sehime Gulsun
    GLOBAL MEDICAL GENETICS, 2021, 8 (03): : 100 - 103
  • [3] An improved tetra-primer PCR approach for the detection of the FGFR3 G380R mutation responsible for achondroplasia
    Etlik, Ozdal
    Koksal, Vedat
    Arican-Baris, Saniye Tugba
    Baris, Ibrahim
    MOLECULAR AND CELLULAR PROBES, 2008, 22 (02) : 71 - 75
  • [4] Expression of FGFR3 carrying the G380R achondroplasia mutation in rodent chondrocytes: Effects on proliferation, differentiation and apoptosis.
    Henderson, JE
    Naski, M
    Ornitz, DM
    Goltzman, D
    Karaplis, AC
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : 33 - 33
  • [5] Expression of FGFR3 with the G380R achondroplasia mutation inhibits proliferation and maturation of CFK2 chondrocytic cells
    Henderson, JE
    Naski, MC
    Aarts, MM
    Wang, DS
    Cheng, L
    Goltzman, D
    Ornitz, DM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) : 155 - 165
  • [6] Achondroplasia with the FGFR3 1138g→a (G380R) mutation in two sibs sharing a 4p haplotype derived from their unaffected father
    Sobetzko, D
    Braga, S
    Rüdeberg, A
    Superti-Furga, A
    JOURNAL OF MEDICAL GENETICS, 2000, 37 (12) : 958 - 959
  • [7] An induced pluripotent stem cell line (GZHMCi003-A) derived from a fetus with exon 3 heterozygous deletion in RUNX2 gene causing cleidocranial dysplasia
    Chen, Min
    Lin, Sheng Mou
    Li, Nan
    Li, Yingting
    Li, Yufan
    Zhang, Luting
    STEM CELL RESEARCH, 2021, 51
  • [8] Increased p21 expression in chondrocytes of achondroplasic children independently from the presence of the G380R FGFR3 mutation
    Parafioriti, Antonina
    Del Bianco, Silvia
    Barisani, Donatella
    Armiraglio, Elisabetta
    Peretti, Giovanni
    Albisetti, Walter
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2009, 14 (05) : 623 - 630
  • [9] Establishment of a human induced pluripotent stem cell line (ABi004-A) carrying a compound heterozygous mutation in the KCNV2 gene
    Alsalloum, Almaqdad
    Shefer, Kristina
    Bogdanov, Pavel
    Mingaleva, Natalia
    Kim, Alexander
    Feoktistova, Sofya
    Mityaeva, Olga
    Volchkov, Pavel
    STEM CELL RESEARCH, 2024, 80
  • [10] Generation of human induced pluripotent stem cell line (XWHNi004-A) from a male with APOE gene mutation
    Wang, Pin
    Sun, Wenxian
    Gong, Jin
    Han, Xiaodong
    Xu, Chang
    Chen, Yufei
    Yang, Yuting
    Luan, Heya
    Li, Shaoqi
    Li, Ruina
    Wen, Boye
    Lv, Sirong
    Chen, Runqi
    Guo, Jinxuan
    Wei, Cuibai
    STEM CELL RESEARCH, 2024, 77
12345